Association between Participation in Government Subsidy Program for Domestic Travel and Symptoms Indicative of COVID-19 Infection
Association between Participation in Government Subsidy Program for Domestic Travel and Symptoms Indicative of COVID-19 Infection
复制标题
参加国内旅行政府补贴计划与 COVID-19 感染症状之间的关联
DOI：
--
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Y. Tsugawa
中科院分区：
文献类型：
--
作者：
A. Miyawaki;T. Tabuchi;Y. Tomata;Y. Tsugawa
重要性：作为应对冠状病毒2019(新冠肺炎)大流行导致的经济低迷的对策，许多国家已经推出或考虑对人们从事旅游和使用餐馆等经济活动提供财政激励。自2020年7月以来，日本实施了一项大规模的全国性政府资助计划，为所有旅行费用提供高达50%的补贴，旨在重振旅游业。然而，目前尚不清楚这种政府旅行补贴对新冠肺炎疫情的影响。目的：探讨参加日本国内旅游政府补贴与新冠肺炎感染发生率之间的关系。设计、背景和参与者：使用2020年8月25日至9月30日在日本进行的一项大型互联网调查的数据，我们检查了使用补贴的个人是否出现指示新冠肺炎感染的症状的可能性更高。曝光率：参加政府国内旅行补贴计划。主要结果和指标：调查过去一个月内出现的五种新冠肺炎感染症状(高烧、喉咙痛、咳嗽、头痛、嗅觉障碍)。结果：在25482名受访者中(50.3%[12809]名女性；平均年龄48.4[17.4]岁)，3289名(12.9%)参与了调查时的补贴计划。在调整了潜在的混杂因素后，我们发现，补贴计划的参与者表现出更高的高烧发病率(调整后的比率，参与者为4.8%，非参与者为3.7%；调整后的优势比[AOR]，1.9；95%CI，1.4-2.56；p<；0.001)，喉咙痛(20.0%比11.3%；AOR，2.13；95%CI，1.39-3.26；p=0.002)，咳嗽(19.2%比11.2%；AOR 1.97；与非参与者相比，头痛(29.4%比25.5%；AOR 1.26；95%CI，1.09=1.46；p=0.005)，嗅觉和味觉障碍(2.6%比1.7%；AOR 1.66；95%CI；1.16-3.49；p=0.005)。结论和相关性：接受政府国内旅行补贴的参与者出现指示新冠肺炎感染的症状的发生率更高。
Importance: As countermeasures against the economic downturn caused by the coronavirus 2019 (COVID-19) pandemic, many countries have introduced or considering financial incentives for people to engage in economic activities such as travel and use restaurants. Japan has implemented a large-scale, nationwide government-funded program that subsidizes up to 50% of all travel expenses since July 2020 with the aim of reviving the travel industry. However, it remains unknown as to how such provision of government subsidies for travel impacted the COVID-19 pandemic. Objective: To investigate the association between participation in government subsidies for domestic travel in Japan and the incidence of COVID-19 infections. Design, Setting, and Participants: Using the data from a large internet survey conducted between August 25 and September 30, 2020, in Japan, we examined whether individuals who used subsidies experienced a higher likelihood of symptoms indicative of the COVID-19 infection. Exposure: Participation in the government subsidy program for domestic travel. Main Outcomes and Measures: Five symptoms indicative of the COVID-19 infection (high fever, throat pain, cough, headache, and smell and taste disorder) within the past one month of the survey. Results: Of the 25,482 respondents (50.3% [12,809] women; mean [SD] age, 48.4 [17.4] years), 3,289 (12.9%) participated in the subsidy program at the time of survey. After adjusting for potential confounders, we found that the participants of the subsidy program exhibited higher incidence of high fever (adjusted rate, 4.8% for participants vs. 3.7% for non-participants; adjusted odds ratio [aOR], 1.90; 95%CI, 1.40-2.56; p<0.001), throat pain (20.0% vs. 11.3%; aOR, 2.13; 95%CI, 1.39-3.26; p=0.002), cough (19.2% vs. 11.2%; aOR 1.97; 95%CI, 1.28-3.03; p=0.004), headache (29.4% vs. 25.5%; aOR, 1.26; 95%CI, 1.09=1.46; p=0.005), and smell and taste disorder (2.6% vs. 1.7%; aOR 1.66; 95%CI; 1.16-3.49; p=0.01) compared with the non-participants. Conclusion and Relevance: The participants of government subsidies for domestic travel experienced a higher incidence of symptoms indicative of the COVID-19 infection.